Tags » GlaxoSmithKline

Yes, I know it has been a while...

I’m just in the process of looking back at my time on Seroxat and my withdrawal from it. I can’t say what for at the moment, but watch this space…. 710 more words

Drug Marketing

Buckley's Syrup Products Recall [Canada]

Canada/Ottawa: GlaxoSmithKline (“GSK”) Consumer Healthcare Inc. recalls various batch/lots of Buckley’s Syrup Products due to suspected defect in bottle seals and consequential choking hazard. HCSC: … 517 more words

Home & Residential

A pharma giant is paying its new female CEO less than her male predecessor—but that's not a scandal

In a world where women consistently earn less than men, and very few run the biggest corporations, getting paid less than a man might be a cause for concern. 332 more words

Health Canada recalls Buckley's syrup due to potential choking hazard

Health Canada says the makers of Buckley’s cough syrup products have issued a voluntary recall from stores across Canada.

The government agency says certain products have a defective circular plastic seal that is clear or semi-transparent, which could fall into the bottle and present a choking hazard. 119 more words


British high court awards massive payout to child who was permanently damaged by the swine flu vaccine… government tried to suppress the truth for years

Source: NaturalNews.com
Ethan Huff
February 24, 2017

A young man from the U.K. who was seriously injured after being vaccinated for swine flu during the fake pandemic of 2009 has finally received the payout he was due from the British government. 557 more words


GSK warns profits to be hit by generic drugs competition

LONDON (AP) — Pharmaceutical company GlaxoSmithKline saw sales and net earnings grow in the fourth quarter but warned that tougher competition from generic drugmakers this year could depress its earnings. 212 more words


Why GSK's Experimental HIV Drug Could Be a Safer Bet—And a Headache for Gilead

An experimental therapy from GlaxoSmithKline could be just as effective as existing therapies for HIV/AIDS patients without the corresponding risk of toxic side effects, raising the possibility of a challenge to incumbent companies in the space like Gilead . 273 more words